FA-DSPE-PEG2000被DTPA-TBZ封装的量子点的应用
瑞禧生物2024-12-19   作者:ws   来源:
字号大小:

文献:

Tuning molecular aggregation to achieve highly bright AIE dots for NIR-II fluorescence imaging and NIR-I photoacoustic imaging

文献链接:

https://pubs.rsc.org/en/content/articlelanding/2020/sc/d0sc03160g

作者:

Yanzi Xu, Chunbin Li, Ruohan Xu, Ning Zhang, Zhi Wang,Xunan Jing,Zhiwei Yang, Dongfeng Dang, Pengfei Zhang  and Lingjie Meng

相关产品:

FA-DSPE-PEG2000(叶酸-磷脂-聚乙二醇2000)

原文摘要:

Currently, bright aggregation-induced emission luminogens (AIEgens) with high photoluminescence quantum yields (PLQYs) in the NIR-II region are still limited, and thus an efficient strategy to enhance NIR-II fluorescence performance through tuning molecular aggregation is proposed here. The synthesized donor–acceptor tailored AIEgen (DTPA-TBZ) not only exhibits an excellent absorptivity in the NIR-I region, but also good fluorescence signals in the NIR-II region with an emission extending to 1200 nm. Benefiting from such improved intramolecular restriction and aggregation, a significant absolute PLQY value of 8.98% was obtained in solid DTPA-TBZ. Encouragingly, the resulting AIE dots also exhibit a high relative PLQY of up to 11.1% with IR 26 as the reference (PLQY ¼ 0.5%). Finally, the AIE dots were applied in high performance NIR-II fluorescence imaging and NIR-I photoacoustic (PA) imaging: visualization of abdominal vessels, hind limb vasculature, and cerebral vessels with high signal to background ratios was performed via NIR-II imaging; Moreover, PA imaging has also been performed to clearly observe tumors in vivo. These results demonstrate that by finely tuning molecular aggregation in DTPA-TBZ, a good NIR-I absorptivity and a highly emissive fluorescence in the NIR-II region can be achieved simultaneously, finally resulting in a promising dual-modal imaging platform for real-world applications to achieve precise cancer diagnostics.

FA - DSPE - PEG2000 的全称为叶酸 - 1,2 - 二硬脂酰 - sn - 甘油 - 3 - 磷酸乙醇胺 -N - [聚乙二醇 - 2000]。它主要由三部分组成。其中 DSPE(1,2 - 二硬脂酰 - sn - 甘油 - 3 - 磷酸乙醇胺)部分具有亲脂性,这是因为其含有两条硬脂酸的长链脂肪酸,能够与脂质环境相互作用,例如插入脂质双层结构。PEG2000(聚乙二醇分子量约为 2000)具有良好的亲水性,使整个分子具有两亲性,同时聚乙二醇链还可以减少与生物体内非特异性蛋白的结合,延长在体内循环时间。FA(叶酸)是一种活性靶向基团,叶酸受体在许多tumour细胞表面过度表达,通过叶酸与tumour细胞表面受体的特异性结合,可以实现对tumour细胞的靶向作用。基于FA-DSPE-PEG2000的特性,该文献制备DTPA-TBZ封装的量子点,流程如下:

成像示意图 

图:成像示意图

DTPA - TBZ 纳米制剂的制备:

称取适量的 FA - DSPE - PEG2000 置于玻璃容器中。加入有机溶剂使 FA - DSPE - PEG2000 完全溶解。可使用磁力搅拌器在适当温度下搅拌直至形成澄清溶液。将 DTPA - TBZ 缓慢加入到上述溶解有 FA - DSPE - PEG2000 的有机溶剂溶液中。继续搅拌使化合物在溶液中均匀分散,确保化合物与两亲性材料充分接触,形成混合溶液。将含有 DTPA - TBZ 和 FA - DSPE - PEG2000 的混合溶液置于旋转蒸发仪中,在适当的温度和真空度下缓慢蒸发有机溶剂。随着溶剂的挥发,两亲性材料和化合物会逐渐自组装形成纳米结构。当有机溶剂基本挥发完全后,在容器中加入适量的缓冲溶液(如 PBS),使形成的纳米结构充分分散。将分散后的溶液转移至透析袋中。将透析袋置于大量的缓冲溶液(如 PBS)中进行透析,以除去残留的有机溶剂和未封装的化合物。透析过程中可多次更换缓冲溶液,直至透析外液中检测不到有机溶剂和化合物杂质为止。透析完成后,收集透析袋内的溶液,即得到封装有 DTPA - TBZ 的 FA - DSPE - PEG2000 纳米制剂。将制剂在合适的条件下保存。

制备工艺示意图 

图:制备工艺示意图

 

结论:

该文献成功制备出了基于FA-DSPE-PEG2000被DTPA-TBZ封装的量子点。实验结果表明,

合成的供体-受体定制AIEgen(DTPA-TBZ)不仅在NIR-I区域具有良好的吸收能力,而且在NIR-II区域也表现出良好的荧光信号。通过微调DTPA-TBZ的分子聚集,可以同时实现良好的NIR-I吸收率和NIR-II区域的高发射荧光,产生一个有前途的双模态成像平台。